 Umesh Wankhade
Concepts (217)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, High-Fat | 17 | 2025 | 236 | 4.410 |
Why?
| | Adipose Tissue | 5 | 2025 | 204 | 2.620 |
Why?
| | Adipose Tissue, Brown | 6 | 2025 | 44 | 2.140 |
Why?
| | Obesity | 12 | 2025 | 1162 | 1.590 |
Why?
| | Prenatal Exposure Delayed Effects | 4 | 2025 | 197 | 1.590 |
Why?
| | Mice, Inbred C57BL | 18 | 2025 | 1884 | 1.370 |
Why?
| | Mice | 29 | 2025 | 5949 | 1.320 |
Why?
| | Energy Metabolism | 5 | 2025 | 302 | 1.290 |
Why?
| | Adipocytes, Brown | 4 | 2021 | 9 | 1.270 |
Why?
| | Animals | 40 | 2025 | 13505 | 1.200 |
Why?
| | Adipose Tissue, White | 4 | 2023 | 35 | 1.190 |
Why?
| | Stem Cells | 2 | 2018 | 177 | 1.030 |
Why?
| | Thermogenesis | 3 | 2025 | 29 | 0.970 |
Why?
| | Housing, Animal | 1 | 2025 | 18 | 0.960 |
Why?
| | Heat-Shock Proteins | 1 | 2025 | 103 | 0.920 |
Why?
| | Temperature | 1 | 2025 | 183 | 0.890 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 3 | 2012 | 44 | 0.780 |
Why?
| | Fatty Liver | 2 | 2022 | 142 | 0.720 |
Why?
| | Adipocytes, White | 2 | 2018 | 3 | 0.690 |
Why?
| | Transcriptome | 1 | 2023 | 370 | 0.670 |
Why?
| | Diet | 4 | 2022 | 587 | 0.650 |
Why?
| | Disease Models, Animal | 8 | 2024 | 1478 | 0.630 |
Why?
| | Cecum | 5 | 2020 | 61 | 0.600 |
Why?
| | Pregnancy | 5 | 2025 | 2680 | 0.580 |
Why?
| | Fruit | 1 | 2019 | 128 | 0.570 |
Why?
| | Maternal Exposure | 1 | 2018 | 103 | 0.570 |
Why?
| | Cell Separation | 1 | 2017 | 83 | 0.530 |
Why?
| | Fetal Development | 1 | 2016 | 50 | 0.510 |
Why?
| | Adenosine Triphosphate | 1 | 2016 | 205 | 0.500 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2024 | 58 | 0.470 |
Why?
| | Male | 22 | 2025 | 26761 | 0.450 |
Why?
| | Flow Cytometry | 1 | 2017 | 478 | 0.440 |
Why?
| | Methylamines | 2 | 2023 | 20 | 0.430 |
Why?
| | Insulin Resistance | 4 | 2024 | 275 | 0.410 |
Why?
| | Liver | 8 | 2024 | 1156 | 0.400 |
Why?
| | Pregnancy Complications | 1 | 2016 | 400 | 0.370 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2011 | 19 | 0.360 |
Why?
| | Fragaria | 2 | 2022 | 17 | 0.350 |
Why?
| | Bacteria | 5 | 2021 | 228 | 0.350 |
Why?
| | Feces | 4 | 2021 | 153 | 0.350 |
Why?
| | Female | 12 | 2025 | 28171 | 0.350 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2010 | 43 | 0.340 |
Why?
| | Inflammation | 6 | 2022 | 641 | 0.340 |
Why?
| | Transcription, Genetic | 1 | 2011 | 378 | 0.330 |
Why?
| | Metabolome | 2 | 2022 | 101 | 0.320 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 560 | 0.320 |
Why?
| | Gene Deletion | 1 | 2010 | 272 | 0.320 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2022 | 137 | 0.310 |
Why?
| | Sex Characteristics | 2 | 2019 | 198 | 0.270 |
Why?
| | Mice, Knockout | 4 | 2021 | 879 | 0.270 |
Why?
| | Gene Expression Profiling | 3 | 2019 | 1105 | 0.260 |
Why?
| | Transforming Growth Factor beta1 | 2 | 2018 | 62 | 0.250 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 990 | 0.250 |
Why?
| | Metabolic Networks and Pathways | 3 | 2020 | 93 | 0.230 |
Why?
| | Antigens, Differentiation | 2 | 2017 | 16 | 0.220 |
Why?
| | Tocotrienols | 1 | 2024 | 37 | 0.220 |
Why?
| | Bile Acids and Salts | 3 | 2019 | 80 | 0.220 |
Why?
| | Drinking Water | 1 | 2023 | 13 | 0.220 |
Why?
| | Glucose | 4 | 2024 | 355 | 0.210 |
Why?
| | Lipid Metabolism | 3 | 2019 | 187 | 0.210 |
Why?
| | Adrenergic beta-3 Receptor Agonists | 1 | 2023 | 3 | 0.210 |
Why?
| | Phylogeny | 3 | 2021 | 231 | 0.210 |
Why?
| | Homeostasis | 1 | 2024 | 201 | 0.210 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 145 | 0.200 |
Why?
| | Dietary Supplements | 2 | 2024 | 465 | 0.200 |
Why?
| | Cordyceps | 1 | 2022 | 1 | 0.200 |
Why?
| | Biodiversity | 2 | 2021 | 52 | 0.190 |
Why?
| | Prader-Willi Syndrome | 1 | 2022 | 7 | 0.190 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2022 | 3 | 0.190 |
Why?
| | Diabetic Angiopathies | 1 | 2022 | 23 | 0.190 |
Why?
| | Adipocytes | 1 | 2023 | 132 | 0.190 |
Why?
| | Choline | 2 | 2023 | 64 | 0.190 |
Why?
| | Running | 2 | 2019 | 22 | 0.190 |
Why?
| | Metabolomics | 2 | 2020 | 150 | 0.190 |
Why?
| | Adipogenesis | 2 | 2019 | 49 | 0.190 |
Why?
| | Metagenomics | 2 | 2018 | 46 | 0.190 |
Why?
| | Phenylpropionates | 1 | 2021 | 13 | 0.180 |
Why?
| | Hippurates | 1 | 2021 | 10 | 0.180 |
Why?
| | Myoglobin | 1 | 2021 | 25 | 0.180 |
Why?
| | Species Specificity | 1 | 2021 | 192 | 0.170 |
Why?
| | Tryptophan | 1 | 2021 | 89 | 0.170 |
Why?
| | Alzheimer Disease | 1 | 2024 | 332 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 56 | 0.170 |
Why?
| | Bone and Bones | 1 | 2024 | 494 | 0.170 |
Why?
| | Histones | 1 | 2022 | 314 | 0.170 |
Why?
| | Trehalose | 1 | 2019 | 6 | 0.170 |
Why?
| | Weight Gain | 2 | 2018 | 240 | 0.160 |
Why?
| | Proto-Oncogenes | 1 | 2019 | 27 | 0.160 |
Why?
| | Cell Differentiation | 2 | 2021 | 665 | 0.160 |
Why?
| | Signal Transduction | 2 | 2018 | 1671 | 0.160 |
Why?
| | Humans | 10 | 2025 | 52483 | 0.160 |
Why?
| | Clostridium Infections | 1 | 2019 | 55 | 0.150 |
Why?
| | GTP-Binding Proteins | 1 | 2019 | 85 | 0.150 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 59 | 0.150 |
Why?
| | Metagenome | 1 | 2018 | 40 | 0.150 |
Why?
| | Prediabetic State | 1 | 2018 | 22 | 0.150 |
Why?
| | Bone Resorption | 1 | 2021 | 302 | 0.150 |
Why?
| | Body Weight | 2 | 2019 | 523 | 0.150 |
Why?
| | Osteogenesis | 1 | 2021 | 366 | 0.140 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 406 | 0.140 |
Why?
| | Fructose | 1 | 2017 | 22 | 0.140 |
Why?
| | Cholesterol, Dietary | 1 | 2017 | 19 | 0.140 |
Why?
| | Overnutrition | 1 | 2017 | 11 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 164 | 0.140 |
Why?
| | Choline Deficiency | 1 | 2017 | 23 | 0.140 |
Why?
| | DNA Methylation | 2 | 2022 | 592 | 0.140 |
Why?
| | Ecosystem | 1 | 2018 | 96 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2022 | 2279 | 0.130 |
Why?
| | Milk Proteins | 1 | 2017 | 77 | 0.130 |
Why?
| | Immunophenotyping | 1 | 2017 | 117 | 0.130 |
Why?
| | Exercise Tolerance | 1 | 2016 | 46 | 0.130 |
Why?
| | Methionine | 1 | 2017 | 136 | 0.130 |
Why?
| | Macrophages | 2 | 2010 | 379 | 0.130 |
Why?
| | Aging | 1 | 2021 | 701 | 0.130 |
Why?
| | Epigenomics | 1 | 2016 | 75 | 0.130 |
Why?
| | Fasting | 2 | 2019 | 75 | 0.120 |
Why?
| | Software | 1 | 2018 | 280 | 0.120 |
Why?
| | Soybean Proteins | 1 | 2017 | 162 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2019 | 333 | 0.120 |
Why?
| | RNA, Messenger | 2 | 2021 | 1132 | 0.110 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2013 | 1 | 0.110 |
Why?
| | Rats | 4 | 2022 | 3220 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 778 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2019 | 804 | 0.100 |
Why?
| | Fatty Acids | 3 | 2019 | 149 | 0.100 |
Why?
| | RNA Stability | 1 | 2012 | 25 | 0.100 |
Why?
| | E-Box Elements | 1 | 2011 | 4 | 0.090 |
Why?
| | Hypothalamus | 1 | 2011 | 44 | 0.090 |
Why?
| | Transcriptional Activation | 1 | 2011 | 122 | 0.090 |
Why?
| | Swine | 3 | 2018 | 428 | 0.090 |
Why?
| | Plant Extracts | 2 | 2024 | 194 | 0.090 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 118 | 0.090 |
Why?
| | RNA Interference | 1 | 2011 | 181 | 0.090 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 46 | 0.090 |
Why?
| | Body Temperature | 1 | 2010 | 78 | 0.090 |
Why?
| | Base Sequence | 1 | 2011 | 640 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 505 | 0.080 |
Why?
| | Leptin | 1 | 2010 | 148 | 0.080 |
Why?
| | Triglycerides | 3 | 2017 | 165 | 0.080 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 467 | 0.080 |
Why?
| | Cell Line | 1 | 2011 | 1030 | 0.070 |
Why?
| | Dietary Fats | 2 | 2019 | 130 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2023 | 807 | 0.070 |
Why?
| | Abscisic Acid | 1 | 2007 | 6 | 0.070 |
Why?
| | Chemokine CCL2 | 1 | 2007 | 69 | 0.070 |
Why?
| | Gene Expression | 2 | 2021 | 618 | 0.070 |
Why?
| | PPAR gamma | 1 | 2007 | 72 | 0.070 |
Why?
| | Dietary Carbohydrates | 2 | 2017 | 90 | 0.060 |
Why?
| | Mice, Inbred Strains | 2 | 2022 | 163 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2020 | 1563 | 0.060 |
Why?
| | Blood Glucose | 2 | 2024 | 473 | 0.060 |
Why?
| | Bixaceae | 1 | 2024 | 6 | 0.060 |
Why?
| | Mice, Obese | 1 | 2024 | 22 | 0.060 |
Why?
| | Carotenoids | 1 | 2024 | 26 | 0.060 |
Why?
| | Mice, Inbred CBA | 1 | 2023 | 37 | 0.050 |
Why?
| | Acetylation | 1 | 2022 | 95 | 0.050 |
Why?
| | RNA, Small Nucleolar | 1 | 2022 | 3 | 0.050 |
Why?
| | Ceramides | 1 | 2022 | 34 | 0.050 |
Why?
| | Electron Transport Complex IV | 1 | 2021 | 24 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 146 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 155 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2022 | 246 | 0.040 |
Why?
| | Disaccharidases | 1 | 2019 | 3 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 94 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2022 | 262 | 0.040 |
Why?
| | Caco-2 Cells | 1 | 2019 | 31 | 0.040 |
Why?
| | Lipogenesis | 1 | 2019 | 31 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 62 | 0.040 |
Why?
| | Phenotype | 2 | 2016 | 789 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2021 | 249 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 31 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 229 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2019 | 70 | 0.040 |
Why?
| | Bacteroides | 1 | 2018 | 14 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 100 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 190 | 0.040 |
Why?
| | Receptors, Leptin | 1 | 2019 | 52 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2019 | 224 | 0.040 |
Why?
| | Oxygen | 1 | 2021 | 336 | 0.040 |
Why?
| | Programming Languages | 1 | 2018 | 6 | 0.040 |
Why?
| | Microbiology | 1 | 2018 | 6 | 0.040 |
Why?
| | Microbiological Techniques | 1 | 2018 | 8 | 0.040 |
Why?
| | Sequence Analysis | 1 | 2018 | 8 | 0.040 |
Why?
| | Population Dynamics | 1 | 2018 | 20 | 0.040 |
Why?
| | Cytokines | 1 | 2021 | 623 | 0.040 |
Why?
| | Rats, Inbred OLETF | 1 | 2017 | 9 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 1567 | 0.030 |
Why?
| | Mitochondria | 1 | 2021 | 430 | 0.030 |
Why?
| | Mitochondria, Liver | 1 | 2017 | 69 | 0.030 |
Why?
| | Ileum | 1 | 2017 | 88 | 0.030 |
Why?
| | Eating | 1 | 2017 | 159 | 0.030 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 202 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2019 | 361 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 362 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2016 | 187 | 0.030 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 316 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2016 | 115 | 0.030 |
Why?
| | Energy Intake | 1 | 2016 | 174 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2013 | 22 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2013 | 39 | 0.030 |
Why?
| | COS Cells | 1 | 2013 | 73 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2013 | 123 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2013 | 72 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 528 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 312 | 0.030 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2012 | 21 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2013 | 177 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2012 | 55 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 55 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 125 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 807 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2012 | 85 | 0.020 |
Why?
| | Protein Conformation | 1 | 2012 | 176 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 552 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 578 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 2968 | 0.020 |
Why?
| | Child | 1 | 2022 | 7248 | 0.020 |
Why?
|
|
Wankhade's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|